The impact of total mesorectal excision in middle and low rectal carcinomas

被引:0
|
作者
Tentes, A. A. K. [1 ]
Korakianitis, O. S. [2 ]
Veliovic, D. [3 ]
Sgouridou, E. [1 ]
Karagiozoglou, C. [2 ]
Moustakas, K. [1 ]
机构
[1] Didimotichon Gen Hosp, Dept Surg, Didimotichon 68300, Greece
[2] Didimotichon Gen Hosp, Dept Anesthesiol, Didimotichon 68300, Greece
[3] Didimotichon Gen Hosp, Dept Radiol, Didimotichon 68300, Greece
来源
JOURNAL OF BUON | 2010年 / 15卷 / 01期
关键词
locoregional recurrence; rectal cancer; survival; total mesorectal excision; PREOPERATIVE RADIOTHERAPY; ANTERIOR RESECTION; LOCAL RECURRENCE; CANCER; EXPERIENCE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The incidence of locoregional recurrence in rectal cancer has declined since total mesorectal excision (TME) has been widely adopted. The purpose of this study was to investigate the long-term survival and the incidence of locoregional recurrences in patients with middle and low rectal carcinomas undergoing TME. Methods: The medical records of 126 patients with middle and low rectal carcinomas treated from 1987-2007 were retrospectively reviewed. Of them 80 had undergone total mesorectal excision (TME-group) and 46 surgery with conventional methods (CON-group). Clinical variables were correlated to morbidity, hospital mortality, recurrence, sites of recurrence, and survival. Results: The groups were comparable except for type of surgery and sites of recurrence. Five-year overall survival rate for TME group was 75% and for CON-group 47% (p=0.0346). Although the groups were not different for the total number of recurrences, the number of locoregional recurrences was significantly lower in TME group (p=0.004). Conclusion: TME appears to improve long-term survival in patients with middle and low rectal carcinomas. The incidence of locoregional recurrence is also reduced by TME.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 50 条
  • [1] Transanal total mesorectal excision for low and middle rectal cancer: time for audit?
    M. Aubert
    D. Mege
    Y. Panis
    Techniques in Coloproctology, 2019, 23 : 703 - 705
  • [2] Transanal total mesorectal excision for low and middle rectal cancer: time for audit?
    Aubert, M.
    Mege, D.
    Panis, Y.
    TECHNIQUES IN COLOPROCTOLOGY, 2019, 23 (08) : 703 - 705
  • [3] Laparoscopic total mesorectal excision for low rectal cancer
    M. Adamina
    C. P. Delaney
    Surgical Endoscopy, 2011, 25 : 2738 - 2741
  • [4] Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis
    Persiani, Roberto
    Biondi, Alberto
    Pennestri, Francesco
    Fico, Valeria
    De Simone, Veronica
    Tirelli, Flavio
    Santullo, Francesco
    D'Ugo, Domenico
    DISEASES OF THE COLON & RECTUM, 2018, 61 (07) : 809 - 816
  • [5] Laparoscopic total mesorectal excision for low rectal cancer
    Adamina, M.
    Delaney, C. P.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (08): : 2738 - 2741
  • [6] Transanal total mesorectal excision for locally advanced middle-low rectal cancers
    Thien, H. H.
    Hiep, P. N.
    Thanh, P. H.
    Xuan, N. T.
    Trung, T. N.
    Vy, P. T.
    Dong, P. X.
    Hieu, M. T.
    Son, N. H.
    BJS OPEN, 2020, 4 (02): : 268 - 273
  • [8] Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
    Lim, Yon Kuei
    Law, Wai Lun
    Liu, Rico
    Poon, Jensen T. C.
    Fan, Joe F. M.
    Lo, Oswens S. H.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [9] Delayed colo-anal anastomosis is an alternative to prophylactic diverting stoma after total mesorectal excision for middle and low rectal carcinomas
    Jarry, J.
    Faucheron, J. L.
    Moreno, W.
    Bellera, C. A.
    Evrard, S.
    EJSO, 2011, 37 (02): : 127 - 133
  • [10] Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
    Yon Kuei Lim
    Wai Lun Law
    Rico Liu
    Jensen TC Poon
    Joe FM Fan
    Oswens SH Lo
    World Journal of Surgical Oncology, 8